Physician profile
Joshua E Logan
NPI 1902067390
$15,574.92
in general payments reported to CMS, 2019-2025
28 companies · $494 in 2025
The $494 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $80.13 · 2021: $13K · 2022: $483 · 2023: $669 · 2024: $505 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.04 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,579.60 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $621.02 | 2019-2024 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $516.81 | 2019-2025 | Lithovue, Lithoclast, Polaris Ultra |
| Janssen Biotech, INC. | $398.00 | 2019-2024 | Akeega, Erleada |
| Sumitomo Pharma America, INC. | $226.24 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $159.12 | 2019-2025 | |
| Rochester Medical Corporation | $137.49 | 2022 | |
| 180 Medical, INC. | $135.13 | 2019-2025 | Gentlecath |
| Pfizer INC. | $94.53 | 2019-2023 | |
| Astellas Pharma US INC | $87.01 | 2019-2025 | Xtandi, Myrbetriq |
| Tersera Therapeutics LLC | $55.30 | 2022 | |
| Laborie Medical Technologies Corp. | $54.09 | 2021-2024 | Endosheath Technology |
| Myovant Sciences INC. | $51.40 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $49.11 | 2020-2024 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $48.93 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $46.88 | 2019-2025 | Itind System |
| Edap Technomed INC | $42.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $38.75 | 2025 | |
| Allergan, INC. | $36.25 | 2019-2021 | |
| Insmed, INC. | $35.00 | 2019 | |
| Urogen Pharma, INC. | $32.66 | 2021-2022 | |
| Amgen INC. | $32.14 | 2019 | |
| Seagen INC. | $21.97 | 2020 | |
| Angiodynamics, INC. | $19.15 | 2024 | Nanoknife |
| Endo Pharmaceuticals INC. | $14.61 | 2019 | |
| Photocure INC | $14.22 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.14 | 2020 | |
| Myriad Genetic Laboratories, INC. | $13.37 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.